Skin immunofluorescence studies on lupus erythematosus and other antinuclear-antibody-positive diseases.
D000974:Antibodies, Antinuclear / Q000032:analysis*; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000473:pathology*; D001706:Biopsy; D003240:Connective Tissue Diseases / Q000276:immunology / Q000473:pathology; D005455:Fluorescent Antibody Technique; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000473:pathology*; D008177:Lupus Vulgaris / Q000139:chemically induced / Q000276:immunology / Q000473:pathology*; D011342:Procainamide / Q000009:adverse effects; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000473:pathology
D000974:Antibodies, Antinuclear; D011342:Procainamide